Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Henry Meds vs June Health

Henry Meds
Graded #48

Higher grade

vs+14.3
June Health
Graded #288

Lower grade

The verdict

Henry Meds takes it — 77.3/100 to 63/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHenry Meds +11
72
61
Dose & formulationHenry Meds +5
80
75
Clinical oversightHenry Meds +21
80
59
Labs & monitoringHenry Meds +27
78
51
FulfillmentHenry Meds +4
78
74
Contract termsHenry Meds +23
78
55
Henry Meds · left barJune Health · right bar

The numbers

MetricHenry MedsJune Health
WeighScore77.3/10063/100
GradeC+C
Scorecard rank#48#288
Semaglutide$197/mo (injectable; 12-month plan paid upfront in full, $2,364)$179/mo (starting dose, compounded)
Tirzepatide$234/mo (compounded oral tablets; 12-month plan paid upfront in full, $2,808)$179/mo (starting dose, compounded)
CoverageMulti-stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Henry Meds

Graded #48 · C+

Strengths

  • Published plan prices identify their upfront-payment requirement
  • Medication, provider access, applicable supplies and shipping included if prescribed
  • Compounded injectable semaglutide and oral options listed

Where it loses points

  • The $197 semaglutide headline requires $2,364 upfront, not monthly payments
  • The listed $234 tirzepatide offer is oral compounded medication, not an injectable quote
  • Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
June Health

Graded #288 · C

Strengths

  • Offers both injectable and oral compounded semaglutide and tirzepatide
  • Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
  • Full per-dose price list published on-site with no signup required to view it
  • Provider consult ('licensed clinician evaluation') is bundled into the displayed price
  • Free discreet shipping advertised with 2-3 day delivery

Where it loses points

  • No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
  • No LegitScript seal or other pharmacy-verification badge found anywhere on the site
  • Legal entity, prescribing medical group, and compounding pharmacy partner are not named
  • Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
  • Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use

Also worth a look

Another provider to compare: CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard